
Pasobolong, Zamboanga City
MINDANAO CENTRAL SANITARIUM & GENERAL HOSPITAL
Department of Health
Republic of the Philippines





Leprosy Training - Pagadian City



Leprosy is a chronic infectious disease caused by Mycobacterium leprae, an acid-fast, rod-shaped bacillus that mainly affects the skin, peripheral nerves, mucosa of the upper respiratory tract and eyes.
Leprosy Training - Zamboanga Sibugay






Leprosy Training - Dipolog City



Leprosy Training - Zamboanga City




THE ORGANISM ( Mycobacterium leprae )
- Gerhard Hansen demonstrated the organism for the first
time in 1873.
- Morphology: a slow growing rod-shaped acid fast bacillus
- Doubling time: 2 weeks
CHARACTERISTICS
- does not grow in laboratory media
- only grows in mice, armadillo, monkey & man
HABITAT
Schwann cell of peripheral nerves
Skin and Mucous membrane
Mode of Transmission:
Respiratory – droplet infection in 95% of cases
Skin – open wounds in 5% of cases
Diagnosis of leprosy:
suspected in people with any of the
following signs and symptoms:
1. pale or reddish patches on the skin
(the most common sign of leprosy)
2. loss or decrease of
feeling in the skin patch
3. numbness or tingling of the hands or feet
4. weakness of the hands, feet or eyelids
5. painful wounds (ulcers) on the hands
and feet
6. painful or tender peripheral nerves
7. swellings or lumps in
the face or earlobes

Gerhard Armauer Hansen demonstrated the organism for
the first time in 1873
LEPROSY
(HANSEN’S DISEASE)




Diagnosis of leprosy: Leprosy is diagnosed by finding at least one of the following cardinal signs:
- Loss of sensation of skin patch
- Enlargement of peripheral nerves
- Presence of acid-fast bacilli in a slit skin smear




TREATMENT OF LEPROSY
Multi-Drug Therapy (MDT)
WHAT IS MDT?
- Multi-Drug Therapy (MDT) is the accepted
standard treatment for leprosy.
- It is a combination of two (2) or more
anti-leprosy drugs:
Dapsone, Rifampicin, Clofazimine

PAUCIBACILLARY regimen (PB) for adult and pediatric patient: 6 blister packs to be taken within 6-9 months consist of Rifampicin, Dapsone

PAUCIBACILLARY regimen (PB) for adult and pediatric patient: 6 blister packs to be taken within 6-9 months consist of Rifampicin, Dapsone


PAUCIBACILLARY regimen (PB) for adult and pediatric patient: 6 blister packs to be taken within 6-9 months consist of Rifampicin, Dapsone

